52 related articles for article (PubMed ID: 38585004)
1. Preoperatively Predicting Survival Outcome for Clinical Stage IA Pure-Solid Non-Small Cell Lung Cancer by Radiomics-based Machine Learning.
Yan H; Niimi T; Matsunaga T; Fukui M; Hattori A; Takamochi K; Suzuki K
J Thorac Cardiovasc Surg; 2024 May; ():. PubMed ID: 38788833
[TBL] [Abstract][Full Text] [Related]
2. Radiomics model based on intratumoral and peritumoral features for predicting major pathological response in non-small cell lung cancer receiving neoadjuvant immunochemotherapy.
Huang D; Lin C; Jiang Y; Xin E; Xu F; Gan Y; Xu R; Wang F; Zhang H; Lou K; Shi L; Hu H
Front Oncol; 2024; 14():1348678. PubMed ID: 38585004
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography.
Mao N; Shi Y; Lian C; Wang Z; Zhang K; Xie H; Zhang H; Chen Q; Cheng G; Xu C; Dai Y
Eur Radiol; 2022 May; 32(5):3207-3219. PubMed ID: 35066632
[TBL] [Abstract][Full Text] [Related]
4. An integrated model combined intra- and peritumoral regions for predicting chemoradiation response of non small cell lung cancers based on radiomics and deep learning.
Ma Y; Li Q
Cancer Radiother; 2023 Dec; 27(8):705-711. PubMed ID: 37932182
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral and peritumoral CT-based radiomics for predicting the microsatellite instability in gastric cancer.
Chen X; Zhuang Z; Pen L; Xue J; Zhu H; Zhang L; Wang D
Abdom Radiol (NY); 2024 May; 49(5):1363-1375. PubMed ID: 38305796
[TBL] [Abstract][Full Text] [Related]
6. A combined predictive model based on radiomics features and clinical factors for disease progression in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
Yang H; Wang L; Shao G; Dong B; Wang F; Wei Y; Li P; Chen H; Chen W; Zheng Y; He Y; Zhao Y; Du X; Sun X; Wang Z; Wang Y; Zhou X; Lai X; Feng W; Shen L; Qiu G; Ji Y; Chen J; Jiang Y; Liu J; Zeng J; Wang C; Zhao Q; Yang X; Hu X; Ma H; Chen Q; Chen M; Jiang H; Xu Y
Front Oncol; 2022; 12():967360. PubMed ID: 35982975
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral and peritumoral radiomics predict pathological response after neoadjuvant chemotherapy against advanced gastric cancer.
Liu C; Li L; Chen X; Huang C; Wang R; Liu Y; Gao J
Insights Imaging; 2024 Jan; 15(1):23. PubMed ID: 38270724
[TBL] [Abstract][Full Text] [Related]
8. uRP: An integrated research platform for one-stop analysis of medical images.
Wu J; Xia Y; Wang X; Wei Y; Liu A; Innanje A; Zheng M; Chen L; Shi J; Wang L; Zhan Y; Zhou XS; Xue Z; Shi F; Shen D
Front Radiol; 2023; 3():1153784. PubMed ID: 37492386
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer.
Liu C; Zhao W; Xie J; Lin H; Hu X; Li C; Shang Y; Wang Y; Jiang Y; Ding M; Peng M; Xu T; Hu A; Huang Y; Gao Y; Liu X; Liu J; Ma F
Front Immunol; 2023; 14():1115291. PubMed ID: 36875128
[TBL] [Abstract][Full Text] [Related]
10. A pre-treatment CT-based weighted radiomic approach combined with clinical characteristics to predict durable clinical benefits of immunotherapy in advanced lung cancer.
Zhu Z; Chen M; Hu G; Pan Z; Han W; Tan W; Zhou Z; Wang M; Mao L; Li X; Sui X; Song L; Xu Y; Song W; Yu Y; Jin Z
Eur Radiol; 2023 Jun; 33(6):3918-3930. PubMed ID: 36515714
[TBL] [Abstract][Full Text] [Related]
11. Effect of histology on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer: A systematic review and meta-analysis.
Li F; Zhai S; Lv Z; Yuan L; Wang S; Jin D; Yi H; Fu L; Mao Y
Front Oncol; 2022; 12():968517. PubMed ID: 36439448
[TBL] [Abstract][Full Text] [Related]
12. Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study.
She Y; He B; Wang F; Zhong Y; Wang T; Liu Z; Yang M; Yu B; Deng J; Sun X; Wu C; Hou L; Zhu Y; Yang Y; Hu H; Dong D; Chen C; Tian J
EBioMedicine; 2022 Dec; 86():104364. PubMed ID: 36395737
[TBL] [Abstract][Full Text] [Related]
13. Predicting chemotherapy response in non-small-cell lung cancer
Chang R; Qi S; Zuo Y; Yue Y; Zhang X; Guan Y; Qian W
Front Oncol; 2022; 12():915835. PubMed ID: 36003781
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]